Freedom of Information request on a copy of the CoV Boost study findings (FOI 21/1087)
Published 27 April 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-4-october-2021/freedom-of-information-request-on-a-copy-of-the-cov-boost-study-findings-foi-211087
6th October 2021
FOI 21/1087
Dear
Thank you for your request dated 27th September where you requested “a copy of the CoV Boost study findings.”
Unfortunately, the information is exempt from release under Section 22 of the Freedom of Information (FOI) Act:
Section 22 – Information intended for future publication: the information you have requested is due to be published. Section 22 is a qualified exemption, which means that we have considered whether the public interest in releasing the information is outweighed by the public interest in not giving the information. In favour of disclosure, we consider that there is a general public benefit from seeing this data. However, we consider that the public interest will be better served by not releasing the information until it is in its complete form.
We intend to publish an annex to the Public Assessment Reports (PARs) for the authorised vaccines in the near future to include information on the authorisation of the third dose.
If you disagree with how we have interpreted the Freedom of Information Act 2000 in answering your request, you can ask for an internal review. Please reply to this email, within two months of this reply, specifying that you would like an Internal Review to be carried out.
Kind regards,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency